FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36541411000001106: Cyproterone 50mg tablets (Stragen UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Feb 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
112378801000001113 Cyproterone 50mg tablets (Stragen UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112378901000001119 Cyproterone 50mg tablets (Stragen UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cyproterone 50mg tablets (Stragen UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Stragen UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Stragen UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Stragen UK Ltd) Is a Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Stragen UK Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Stragen UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Stragen UK Ltd) Has basis of strength substance Cyproterone acetate true Inferred relationship Existential restriction modifier 1
Cyproterone 50mg tablets (Stragen UK Ltd) Has presentation strength numerator value 50 false Inferred relationship Existential restriction modifier 1
Cyproterone 50mg tablets (Stragen UK Ltd) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Cyproterone 50mg tablets (Stragen UK Ltd) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Cyproterone 50mg tablets (Stragen UK Ltd) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Cyproterone 50mg tablets (Stragen UK Ltd) Has precise active ingredient Cyproterone acetate true Inferred relationship Existential restriction modifier 1
Cyproterone 50mg tablets (Stragen UK Ltd) Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Stragen UK Ltd) Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Stragen UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Stragen UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Stragen UK Ltd) Has specific active ingredient Cyproterone acetate true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Stragen UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Stragen UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Stragen UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Cyproterone 50mg tablets (Stragen UK Ltd) 56 tablet Has AMP True Cyproterone 50mg tablets (Stragen UK Ltd) Inferred relationship Existential restriction modifier
Cyproterone 50mg tablets (Stragen UK Ltd) 168 tablet Has AMP True Cyproterone 50mg tablets (Stragen UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start